Eris acquired Biocon Biologics’ domestic branded formulation business for Rs 1,242 crore in Q4FY24 and dermatology and nephrology units in Q3FY24
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Eris acquired Biocon Biologics’ domestic branded formulation business for Rs 1,242 crore in Q4FY24 and dermatology and nephrology units in Q3FY24
| Subscribe To Our Free Newsletter |
